BD Alaris Infusion Central information disclosure | CVE-2022-47376
NAME
__________
BD Alaris Infusion Central information disclosure
Platforms Affected:
Risk Level:
7.3
Exploitability:
Unproven
Consequences:
Obtain Information
DESCRIPTION
__________
BD Alaris Infusion Central could allow a local authenticated attacker to obtain sensitive information, caused by credentials management errors after installation. An attacker could exploit this vulnerability to obtain patient health data and use this information to launch further attacks against the affected system.
CVSS 3.0 Information
__________
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged
Access Vector:
Local
A considerable amount of time and effort goes into maintaining this website, creating backend automation and creating new features and content for you to make actionable intelligence decisions. Everyone that supports the site helps enable new functionality.
If you like the site, please support us on Patreon using the button below
To keep up to date follow us on the below channels.
